Ledger.Open graph →

SEC Form D · filed February 2, 2017

Axxia Pharmaceuticals, LLC

Offering

$3.0M

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

BEL AIR, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Wally P. Grimm · Bel Air, MDDirector Sally P. Macconnell · Bel Air, MDDirector D. P. Cox · Bel Air, MDExec · Director Stuart P. Grossman · Bel Air, MDDirector Wayne Pollock · Bel Air, MDExec · Director Jennifer Carolan · Palo Alto, CADirector Chris Gabrieli · Boston, MADirector Tyler P. Hoffman · Boston, MADirector Nei-Kuan P. Chia · Boston, MAExec · Director Bernard P. Rudnick · Bel Air, MDExec · Director David P. Wheatley · Bel Air, MDDirector Mark P. Roehrenbeck · Boston, MADirector Ivana Faltysova · GRAND CAYMAN, Cayman IslandsDirector Randolph Klueger · WASHINGTON, D.C., Washington, D.C.Director Jeff M. Nunnenkamp · BEND, ORExec · Director Bernard P. Rudnick · Bel Air, MDExec · Director D. P. Cox · Bel Air, MDExec · Director David P. Wheatley · Bel Air, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗